Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
PLoS One. 2011 Feb 3;6(2):e16654. doi: 10.1371/journal.pone.0016654.
Leptin is a peptide hormone playing pivotal role in regulating food intake and energy expenditure. Growing evidence has suggested the pro-inflammatory and fibrogenic properties of leptin. In addition, patients with renal fibrosis have higher level of plasma leptin, which was due to the increased leptin production. Aristolochic acid (AA) is a botanical toxin characterized to associate with the development of renal fibrosis including tubulointerstitial fibrosis. However, whether leptin is upregulated to participate in AA-induced kidney fibrosis remain completely unknown.
METHODOLOGY/PRINCIPAL FINDINGS: In this study, leptin expression was increased by sublethal dose of AA in kidney fibroblast NRK49f determined by enzyme-linked immunosorbent assay and Western blot. Data from real-time reverse transcriptase-polymerase chain reaction revealed that leptin was upregulated by AA at transcriptional level. DNA binding activity of CCAAT enhancer binding protein α (C/EBP α), one of the transcription factors for leptin gene, was enhanced in DNA affinity precipitation assay and chromatin immunoprecipitation experiments. Knockdown of C/EBP α expression by small interfering RNA markedly reduced AA-induced leptin expression. Moreover, AA promoted Akt interaction with p-PDK1, and increased phosphorylated activation of Akt. Akt knockdown, and inhibition of Akt signaling by LY294002 and mTOR inhibitor rapamycin reduced leptin expression. Furthermore, treatment of LY294002 or rapamycin significantly suppressed AA-induced C/EBP α DNA-binding activity. These results suggest that Akt and C/EBP α activation were involved in AA-regulated leptin expression.
CONCLUSIONS/SIGNIFICANCE: Our findings demonstrate the first that AA could induce secretion and expression of fibrogenic leptin in kidney fibroblasts, which reveal potential involvement of leptin in the progression of kidney fibrosis in aristolochic acid nephropathy.
瘦素是一种在调节食物摄入和能量消耗方面发挥关键作用的肽激素。越来越多的证据表明瘦素具有促炎和纤维化的特性。此外,肾纤维化患者的血浆瘦素水平较高,这是由于瘦素产生增加所致。马兜铃酸(AA)是一种植物毒素,其特征在于与肾纤维化的发展有关,包括肾小管间质纤维化。然而,瘦素是否上调参与 AA 诱导的肾纤维化仍然完全未知。
方法/主要发现:在这项研究中,通过酶联免疫吸附试验和 Western blot 测定,亚致死剂量的 AA 可使肾成纤维细胞 NRK49f 中的瘦素表达增加。实时逆转录聚合酶链反应的数据显示,AA 在转录水平上调了瘦素的表达。CCAAT 增强子结合蛋白α(C/EBPα)是瘦素基因的转录因子之一,其 DNA 结合活性在 DNA 亲和力沉淀测定和染色质免疫沉淀实验中增强。用小干扰 RNA 敲低 C/EBPα 的表达可显著减少 AA 诱导的瘦素表达。此外,AA 促进 Akt 与 p-PDK1 的相互作用,并增加 Akt 的磷酸化激活。Akt 敲低和 Akt 信号通路的抑制(通过 LY294002 和 mTOR 抑制剂雷帕霉素)减少了瘦素的表达。此外,LY294002 或雷帕霉素的治疗显著抑制了 AA 诱导的 C/EBPα DNA 结合活性。这些结果表明 Akt 和 C/EBPα 的激活参与了 AA 调节的瘦素表达。
结论/意义:我们的研究结果首次表明,AA 可诱导肾成纤维细胞分泌和表达促纤维化的瘦素,这揭示了瘦素在马兜铃酸肾病中肾纤维化进展中的潜在作用。